Articles in topic: Pharmaceuticals
Page 2
FDA approved INQOVI + venetoclax: oral therapy for AML
FDA approves expansion of Avastin biosimilar production
Teplizumab approved for children: delaying type 1 diabetes
Anifrolumab in autoinjector: FDA approves home treatment for lupus
EMA accepted the application for Dovato for children with HIV
FDA to Review Afrezza: First Needle-Free Insulin for Children
mRNA vaccine Moderna against influenza: trials completed
Subcutaneous Lecanemab: FDA Priority Status 2026
Fidanacogene elaparvovec: EMA approves gene therapy for hemophilia B
Tarlatamab (Imdelltra) approved by FDA: new standard for small cell lung cancer
FDA to Review Generic Dexmethylphenidate CTx-1301
FDA to Review Inhaled Insulin Afrezza for Children
FDA approved Vyvgart for all serotypes of myasthenia gravis
FDA will approve subcutaneous Lecanemab in August 2026
Tasipimidine (Tessie): FDA approval for noise phobia and anxiety
SaRNA vaccine for cats: EMA decision as a breakthrough for medicine
FDA approved Langlara as an interchangeable biosimilar of insulin glargine
Gedatolisib: Phase 3 success in PIK3CA-mutated cancer
Langlara: FDA approved Chinese insulin biosimilar
